Infliximab use for corticosteroid-resistant tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS) in an immunocompetent patient

[1]  F. Tubach,et al.  Paradoxical anti-TNF-associated TB worsening: Frequency and factors associated with IRIS. , 2016, Joint, bone, spine : revue du rhumatisme.

[2]  A. Fauci,et al.  A Paradoxical Treatment for a Paradoxical Condition: Infliximab Use in Three Cases of Mycobacterial IRIS. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  O. Lortholary,et al.  Anti-tumor necrosis factor monoclonal antibody for steroid-dependent TB-IRIS in AIDS. , 2015, AIDS.

[4]  D. Weissman,et al.  Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study. , 2015, The Lancet. Infectious diseases.

[5]  M. Noursadeghi,et al.  Paradoxical reactions and immune reconstitution inflammatory syndrome in tuberculosis. , 2015, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[6]  A. Rodger,et al.  Biomarkers in immune reconstitution inflammatory syndrome: signals from pathogenesis , 2010, Current opinion in HIV and AIDS.

[7]  D Emilie,et al.  Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry. , 2009, Arthritis and rheumatism.

[8]  R. Wallis,et al.  Adalimumab treatment of life-threatening tuberculosis. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  John Chan,et al.  Neutralization of tumor necrosis factor (TNF) by antibody but not TNF receptor fusion molecule exacerbates chronic murine tuberculosis. , 2007, The Journal of infectious diseases.

[10]  E. Vicaut,et al.  Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients , 2006, AIDS.

[11]  R. Wallis.  Reconsidering adjuvant immunotherapy for tuberculosis. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.